Company: FTII
Filing Date: 2025-02-14
Form Type: S-4
Source: 0001493152-25-006997
Chunk: 785

Company: FutureTech II Acquisition Corp.
Filing Date: 2025-02-14
Form: S-4
Chunk 785
---
ENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

FUTURETECH II ACQUISITION CORP.

[Date], 2025</div>

Futuretech II Acquisition Corp.,
a corporation organized and existing under the laws of the State of Delaware (the “Corporation”), DOES HEREBY
CERTIFY AS FOLLOWS:

1. The name of the Corporation
is “Futuretech II Acquisition Corp.” The original certificate of incorporation of the Corporation was filed with the Secretary
of State of the State of Delaware on August 19, 2021 and was amended and restated on February 17, 2022 (the “Certificate”).

2. This second amended and restated
certificate of incorporation (the “Amended and Restated Certificate”), which both restates and amends the provisions
of the Certificate, was duly adopted in accordance with Sections 242 and 245 of the General Corporation Law of the State of Delaware,
as amended from time to time (the “DGCL”), and has been duly approved by the written consent of the stockholders
of the Corporation in accordance with Section 228 of the DGCL.

3. This Amended and Restated Certificate
shall become effective on the date of filing with Secretary of State of Delaware.

4. The text of the Certificate,
as amended to the date hereof, is hereby restated and amended in its entirety to read as follows:

<div align='center'>ARTICLE I

NAME OF THE CORPORATION</div>

The name of the corporation is Longevity Biomedical,
Inc. (the “Corporation”).

<div align='center'>ARTICLE II

REGISTERED AGENT</div>

The address of the Corporation’s registered
office in the State of Delaware is 1675 South State Street, Suite B, Dover, Delaware 19901 in Kent County. The name of its registered
agent at such address is Capitol Services, Inc.

<div align='center'>ARTICLE III

BUSINESS PURPOSE</div>

The nature of the business or purposes to be conducted
or promoted by the Corporation is to engage in any lawful act or activity for which corporations may be organized under the DGCL.

| B-1 |

<div align='center'>ARTICLE IV

CAPITAL STOCK</div>

Section 4.1The total
number of shares of all classes of capital stock, each with a par value of $0.0001 per share, which the Corporation is authorized to issue
is 100